Search

Your search keyword '"Fuwa, Noriko"' showing total 5 results
Start Over Author "Fuwa, Noriko"
5 results on '"Fuwa, Noriko"'

1. 480. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant among Immunocompromised Patients

Author

KAMEGAI, K O H E I, primary, Iwamoto, Noriko, additional, Itoh, Naoya, additional, Ishikane, Masahiro, additional, Asai, Yusuke, additional, Akazawa, Nana, additional, Fuwa, Noriko, additional, Takasaki, Jin, additional, Hojo, Masayuki, additional, Hangaishi, Akira, additional, Togano, Tomiteru, additional, Teruya, Katsuji, additional, Kanno, Takayuki, additional, Takahashi, Kenichiro, additional, Miyamoto, Sho, additional, Hirata, Yuichiro, additional, Saito, Tomoya, additional, Katano, Harutaka, additional, Suzuki, Tadaki, additional, and Ohmagari, Norio, additional

Published
2023
Full Text
View/download PDF

3. Characterization of an EG.5.1 clinical isolate in vitro and in vivo

Author

Uraki, Ryuta, primary, Kiso, Maki, additional, Iwatsuki-Horimoto, Kiyoko, additional, Yamayoshi, Seiya, additional, Ito, Mutsumi, additional, Chiba, Shiho, additional, Sakai-Tagawa, Yuko, additional, Imai, Masaki, additional, Kashima, Yukie, additional, Koga, Michiko, additional, Fuwa, Noriko, additional, Okumura, Nobumasa, additional, Hojo, Masayuki, additional, Iwamoto, Noriko, additional, Kato, Hideaki, additional, Nakajima, Hideaki, additional, Ohmagari, Norio, additional, Yotsuyanagi, Hiroshi, additional, Suzuki, Yutaka, additional, and Kawaoka, Yoshihiro, additional

Published
2023
Full Text
View/download PDF

4. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo

Author

Uraki, Ryuta, Kiso, Maki, Iwatsuki-Horimoto, Kiyoko, Yamayoshi, Seiya, Ito, Mutsumi, Chiba, Shiho, Sakai-Tagawa, Yuko, Imai, Masaki, Kashima, Yukie, Koga, Michiko, Fuwa, Noriko, Okumura, Nobumasa, Hojo, Masayuki, Iwamoto, Noriko, Kato, Hideaki, Nakajima, Hideaki, Ohmagari, Norio, Yotsuyanagi, Hiroshi, Suzuki, Yutaka, and Kawaoka, Yoshihiro

Published
2023
Full Text
View/download PDF

5. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitroand in vivo

Author

Uraki, Ryuta, Kiso, Maki, Iwatsuki-Horimoto, Kiyoko, Yamayoshi, Seiya, Ito, Mutsumi, Chiba, Shiho, Sakai-Tagawa, Yuko, Imai, Masaki, Kashima, Yukie, Koga, Michiko, Fuwa, Noriko, Okumura, Nobumasa, Hojo, Masayuki, Iwamoto, Noriko, Kato, Hideaki, Nakajima, Hideaki, Ohmagari, Norio, Yotsuyanagi, Hiroshi, Suzuki, Yutaka, and Kawaoka, Yoshihiro

Abstract

EG.5.1 is a subvariant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron XBB variant that is rapidly increasing in prevalence worldwide. However, the pathogenicity, transmissibility, and immune evasion properties of isolates of EG.5.1 are largely unknown. Here, we show that there are no obvious differences in growth ability and pathogenicity between EG.5.1 and XBB.1.5 in hamsters. We also demonstrate that, like XBB.1.5, EG.5.1 is transmitted more efficiently between hamsters compared to its predecessor, BA.2. In contrast, unlike XBB.1.5, we detect EG.5.1 in the lungs of four of six exposed hamsters, suggesting that the virus properties of EG.5.1 are different from those of XBB.1.5. Finally, we find that the neutralizing activity of plasma from convalescent individuals against EG.5.1 was slightly, but significantly, lower than that against XBB.1.5 or XBB.1.9.2. Our data suggest that the different virus properties after transmission and the altered antigenicity of EG.5.1 may be driving its increasing prevalence over XBB.1.5 in humans.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results